Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tatsunori Kiriu
Pseudo-Progression and the Neutrophil-To-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors: A Case–Control Study
OncoTargets and Therapy
Oncology
Pharmacology
A Multi-Center, Phase II Trial of Nab-Paclitaxel and Gemcitabine in Patients With Non-Small-Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
Cancer Management and Research
Oncology
Related publications
Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer
Cancer
Cancer Research
Oncology
When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?
Current Treatment Options in Oncology
Oncology
Pharmacology
P2.01-82 Neutrophil-To-Lymphocyte Ratio Complements the Prognostic Ability of PD-L1 in Non-Small Cell Lung Cancer Treated With PD-1/PD-L1 Inhibitors
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Neutrophil-To-Lymphocyte Ratio as an Early Marker of Outcomes in Patients With Advanced Non-Small-Cell Lung Cancer Treated With Nivolumab
International Journal of Clinical Oncology
Medicine
Surgery
Oncology
Hematology
Initial Experience After Transition to Immune Checkpoint Inhibitors in Patients With Non-Small Cell Lung Cancer Treated in a Rural Healthcare Region
Cureus
Peripheral Blood Markers Identify Risk of Immune‐Related Toxicity in Advanced Non‐Small Cell Lung Cancer Treated With Immune‐Checkpoint Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
Neutrophil-Lymphocyte Ratio Predicts Recurrence in Patients With Resected Stage 1 Non-Small Cell Lung Cancer
Journal of Cardiothoracic Surgery
Cardiology
Cardiovascular Medicine
Medicine
Pulmonary
Respiratory Medicine
Surgery
Checkpoint Inhibitors in Squamous Non-Small Cell Lung Cancer (NSCLC)
Open Access Journal of Oncology and Medicine
Immune Checkpoint Modulation for Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology